Return
| International Stem Cell Meeting & Biomed Israel | 07-05-07 |
On June 5-7, the International Stem Cell Meeting & ILSI Biomed Israel 2007 will take place in Tel Aviv.
Last year's program already took into consideration the assimilation of biotech and medical device (Biomed – being their brand name) and in each of the sessions (cardiology, orthopedics, nerve-stimulation) the combination of the two disciplines has been emphasized. ILSI-Biomed 2007 will be a natural extension of the same approach of converging medical device, diagnostics and biotechnology. Just as a catalyst of attraction.
For more information, please visit www.kenes.com/biomed/.
Last year's program already took into consideration the assimilation of biotech and medical device (Biomed – being their brand name) and in each of the sessions (cardiology, orthopedics, nerve-stimulation) the combination of the two disciplines has been emphasized. ILSI-Biomed 2007 will be a natural extension of the same approach of converging medical device, diagnostics and biotechnology. Just as a catalyst of attraction.
For more information, please visit www.kenes.com/biomed/.
Just to highlight a few leading aspects:
1) The International Stem Cell Meeting: Stem Cells and their Regulatory Microenvironment .
Together with the Weizmann Institute the conference will revisit the whole area of stem cell research including review of the basics, analysis of the IP / patent policy, trends in the industrialization process and convergence with medical device approaches.
2) Innovations Bio-Pharma and Medical Device: Preliminary agenda will be published shortly
3) BioBusiness: From a scientific discovery to a profitable industryopportunities and hurdles. A series of panel discussions will address the crossroad and meeting site between tech-transfer, regulation, investment at various stages and marketing strategies.
Together with the Weizmann Institute the conference will revisit the whole area of stem cell research including review of the basics, analysis of the IP / patent policy, trends in the industrialization process and convergence with medical device approaches.
2) Innovations Bio-Pharma and Medical Device: Preliminary agenda will be published shortly
3) BioBusiness: From a scientific discovery to a profitable industryopportunities and hurdles. A series of panel discussions will address the crossroad and meeting site between tech-transfer, regulation, investment at various stages and marketing strategies.